Metabolic and cardiorespiratory effects of decreasing lung hyperinflation with budesonide/formoterol in COPD: a randomized, double-crossover, placebo-controlled, multicenter trial

por Divo, Miguel J., DePietro, Michael R., Horton, John R., Maguire, Cherie A., Celli, Bartolome R.
Publicado 2020